REFERENCE:

1. Chien Y.W., Novel Drug Delivery System (IInd Edn), Revised and expanded,
1992,p.no.139-140.

2. Chien Y. W., Novel Drug Delivery System (IInd Edn), Revised and expanded, 1992,
p.no.1-2.

3. Bankers G.S. and Rhodes C.T., Modern Pharmaceutical (3rd Edn), Marcel Deckker,
New York, 1995,p.no.575.

4. Bankers G. S. and Rhodes C.T., Modern Pharmaceutical (3rd Edn), Marcel Deckker,
New York, 1995, p.no.6.

5. Bankers G. S. and Rhodes C.T., Modern Pharmaceutical (3rd Edn), Marcel Deckker,
New York, 1995,p.no.77-578.

6. Bankers G. S. and Rhodes C.T., Modern Pharmaceutical (3rd Edn), Marcel Deckker,
New York, 1995,pno.579-580.

7. Lachman Leon, Liberman H.A> and Kanig J.L., The Theory and Practice of industrial
pharmacy (3rd Edn), Varghese publishing House Bombay, p.no.430.

8. D. M. Brahmankar and Sunil B. Jaiswal, in Biopharmaceutics and Pharmacokinetics,

A Treatise, Vallabh Prakashan, 1st edn, 1995, pg.no.347-371.

9. Lachman Leon, Liberman H. A> and Kanig J.L., The Theory and Practice of industrial
pharmacy (3rd Edn), Varghese publishing House Bombay, p.no.453.

10. Lachman Leon, Liberman H. A. and Kanig J.L., The Theory and Practice of industrial
pharmacy (3rd Edn), Varghese publishing House Bombay, p.no. 443-453.

11. Ruggero Bettini, www. Medfarm unifort/ pharmaco/ itcis / Erasmus/

12. V.H. Lee, J.R. Robinson in Sustained and Controlled Release Drug
Delivery System Marcel Dekker, New York, p 71-121
13. J.lapdus, N.G. Lordi, in Journal of Pharm. Sci 86,08,1991-1992.

14. L. Lachman, H.A. Liberman, J.L Kanig, in, The Theory and Practice of Industrial
Pharmacy 3rd edn Lea and Febiger, Philadelphis, 1987 pg. no. 453

15. P. Colomba, R.Bettini, Manima, in Journal of Pharm. Sci 86,08 1999-1992.

16. Liberman, H.A. Pharmaceutical Dosage Form; Tablets second Edn Vol. I, pp. 136.

17. K. D. Tripathi, Essentials of Medical Pharmacology, Jaypee brothers medical

publishers, New Delhi, 5th , 2003, 495-498.

18. Clara I Vargas and Evone S. Ghaly, in Drug Dev. Ind. pharm, 25 (9), p1045-
1050(1999)

19. J.Lapidus, N.G. Lordi,in, J.Pharm. Sci. 55, p.840,(1966)

20. S.K.Baveja, A. V. Hassan and Amarjit Singh in, Indian J. Pharm. Sci, 55p 249-
250(1989)

21. Guang Yan, Henan Li, ruhua zhang,and Derong Ding, in, Drug Dev. Ind. Pharm,
26(6),p.681-686(2000)

22. T.salsa, F. Veiga,and M.E Pina, in Drug Deve. Ind Pharm, 24(1) p. 1-9(1998)

23. Praveen Khullar, Roop K. Khar and Suraj P. Agarwal, in, Drug Dev. Ind. Pharm.
24(5),p.479-483(1998)

24. Y. madhusudan Roa, J. Krishana Vini and G. Jayasanger, in Drug Delivery

25. Ruckmani K, agul B, and Ghosal S.K, sustained release of nifedipine from eudragit
matrix tablet The Easterm Pharmacist, Nov. 1995, p.no. 137-139

26. Khullar P, khar R.K, and Agrawal S.Ps, Guar gum as a hydrophilic matrix for the
preparation of theophylline controlled released dosage form, Indian Journal of
Pharmaceutical Science Nov-Dec 1999, p.no 342-345.

27. Martindale, The extra Pharmacopoeia ,(33rd edn); 2001,pg. No 1225- 1227.
28. Aithal K.S, Udupa N, controlled Fluoride release tablet using ethyl cellulose and
HPMC Indian Drug, May 1996, p.no.298-303.

29. Murali G.V., Babu M,Sheshasayana A. and Murthy K.V.., preparation and evalution
of Indomethacin ethyl cellulose polymer matrix system The Eastern Pharmacist,
April 2000 p.no 113-114.

30. Talete G.S, Gaud R.S, Formulation and evalution of sustained release dosage form of
flubiprofen using a combined pectin and ethyl cellulose matrix The Eastern
Pharmacist, march 2001, p.no 105-107.

31. Nandi P.K, studies on fabrication of Ibruprofen SR product and its release pattern,
Indian Drug, 35 (5) 11th March 1996.

32. Haider s.s.,monujan n., and shahariyar s.m. sustained release preparation of
metoclopramide hcl based on fatty matrix Indian drug .39(2), feb 200, p. no.73-79

33. C.duru, s. rizk,etal in drug dev. ind. pharm. 20(16),p.no.2563-2573(1994)

34. N. E. Huber, l. b. dale and g.l. christemson , in j. pharm.sci.55.p.no. 947 (1996)

35. N. V. Majeti , Ravi Kumar and Neeraj kumar, in. Drug .Dev.Ind.Pharm, 27(1), p.1-30
(2001).

36. Chandramohan S.B and shamla Bhaskaran studied,"In situ gelling gellan formulation
for oral sustained delivery of famotidine.56th IPC Scientific abstract book, hydrabad
p 13.

37. Indian Pharmacopoeia Government of India. Ministry of Health and Family Welfare,
The controller of publications. New Delhi., Vol-I, 1996; 242.

38. www.Rxlist.com

39. Raymond C. Rowe,Paul.J,Shegkey,& PaulJWeller.,Hand book of pharmaceutical

excipients,4th 1994,pgNo.228, 323, 845, 2180.
40. Varshosaz J, Tavakoli N., Use of hydrophilic natural gums in formulation of sustained
release matrix tablets of Tramadol HCl, AAPS. Pharm. Sci. Tech., 2006, 7(1), Article
24.

41. Lachman L, Liberman HA. Theory and practice of industrial pharmacy. Varghese
publishing house: Mumbai. 3rd, 1990; 171-194.

42. Howard Y Ando and Galen W Radebaugh In Remington: The Science And Practice Of
Pharmacy. Gennaro, A. R. Ed; Mack Publishing Company, 20th, 2000; 700.

43. Vogels text book of practicle organic chemistry Including qualitative organic
analysis 4th, 223-230.

44. Clark, Clarks Analysis of Drugs and Poisons, Pharmaceutical Press, American
Pharmaceutical Association, 2nd, 2004.

45. Skoog A. S., Holler J. F., Timothy A. N., Principle of Instrumental Analysis Thomson
Books/Coles, 1st, 2003, 300-325, 380, 410.

46. Indian Pharmacopoeia Government of India. Ministry of Health and Family Welfare,
The controller of publications. New Delhi., Vol-II, 1996; A-144.

47. Vogels text book of practical organic chemistry including qualitative organic
analysis 4th, 1978, 242-259.

48. Behl A.K and Dhake A.S studies ,Formulation and Release characteristics of
sustained release Ofloxacin tablets. Indian Drugs,2005,42 (5) pg.no316-318.
49. Martins Physical Pharmacy and Pharmaceutical Sciences, Lippincott Williams and
Wilkins, Indian Edition B.I. Publications, 5th, 2006, 533-538, 553-558.

50. Aulton ME. Pharmaceutics: The Science of Dosage Form Design. Second Edn.
Livingstone C. Elsevier Science Ltd. 2002; 315-20.

51. Cooper J., Gunn C., Powder flow and compaction. In: Carter SJ, eds, Tutorial
Pharmacy, New Delhi. India, CBS Publishers and Distributers, 1986, 211-233.
52. H. N. More, A. A. Hazare, Practical Pharmaceutics (Physical pharmacy), Manas
Prakashan, Kolhapur, 1st, 2004, 86-105.

53. Banker G. S., Anderson N. R., In: Leon Lachman, HA Lieberman, JL Kanig, The Theory
and Practice of Industrial Pharmacy, Varghese publishing house: Mumbai, 3rd, 1990,
296-302.

54. Indian Pharmacopoeia Government of India. Ministry of Health and Family Welfare.
55. The controller of publications. New Delhi. 1996; Vol-II, 734-736.

56. United State Pharmacopoeia XXIV NF 24, (2000) United States Pharmacopoeia
convention Rockville, 1941.

57. P. M. Dandgi, V. S. Mastiholimath, et. al., Studies Development and evaluation of

theophylline and salbutamol sulphate sustained release matrix tablet, I. J. Pharm.
Sci., 2005, (67)5, 598-602.

58. Bhaskaran S. and Ramiz M., I. J. Pharm. Sci., 2004, (64), 357.

59. Naim S., Samuel B, Chauhan B., Paradkar A., Effect of potassium chloride and cationic
drug on swelling, erosion and release from K carrageenan, AAP Pharm Sci Tech,
2004, 5(2), 1-8.

60. Vadas E. B., In Remington: The Science And Practice Of Pharmacy. Gennaro, A. R. Ed;
Mack Publishing Company, 20th, 2000; 986-994.